Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)
21.56
+0.65 (3.11%)
May 16, 2025, 3:00 PM CST
Aurisco Pharmaceutical Market Cap
Aurisco Pharmaceutical has a market cap or net worth of 8.76 billion as of May 16, 2025. Its market cap has increased by 0.09% in one year.
Market Cap
8.76B
Enterprise Value
8.74B
Revenue
1.54B
Ranking
n/a
PE Ratio
21.75
Stock Price
21.56
Market Cap Chart
Since September 21, 2020, Aurisco Pharmaceutical's market cap has increased from 4.83B to 8.76B, an increase of 81.24%. That is a compound annual growth rate of 13.64%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 16, 2025 | 8.76B | 2.08% |
Dec 31, 2024 | 8.58B | -18.20% |
Dec 29, 2023 | 10.49B | 4.58% |
Dec 30, 2022 | 10.03B | 13.58% |
Dec 31, 2021 | 8.83B | 38.75% |
Dec 31, 2020 | 6.36B | 31.70% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 342.41B |
Shenzhen Mindray Bio-Medical Electronics | 273.75B |
WuXi AppTec | 174.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 125.91B |
Aier Eye Hospital Group | 118.54B |
Shanghai United Imaging Healthcare | 113.02B |
Sichuan Biokin Pharmaceutical | 109.04B |
Yunnan Baiyao Group Co.,Ltd | 101.22B |